Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PEDIAVIR

Financiado

Cerrado

New Therapeutics Strategies for the Treatment of Pediatric Brain Tumors

High-risk pediatric brain tumors constitute the leading cause of cancer death in children and despite the improvement of diagnostic and therapeutic approaches children with these malignancies have a very poor prognosis. Thus, it i... ver más

31/03/2015

UPNA

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

UNIVERSIDAD DE NAVARRA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 849

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-03-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UPNA

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ITCC-P4 ITCC Pediatric Preclinical POC Platform Sofia ref. 116064 20M€ Cerrado

Decode Relapse Decoding and Targeting Treatment-Resistant Metastatic Neurob... 2M€ Cerrado

RhabdoEvo Deciphering the cellular origin and evolution of malignant r... 2M€ Cerrado

INTIGT Identification of novel targets to improve glioblastoma ther... 212K€ Cerrado

RESISTANCEPROGRAMS Tumor recurrence and therapeutic resistance: exploring and e... 2M€ Cerrado

CanSel Highly selective customizable therapy for metastatic tumors 166K€ Cerrado

Líder del proyecto

UNIVERSIDAD DE NAVARRA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 849

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto High-risk pediatric brain tumors constitute the leading cause of cancer death in children and despite the improvement of diagnostic and therapeutic approaches children with these malignancies have a very poor prognosis. Thus, it is clear that the management of these malignancies is suboptimal and novel targeted therapeutic strategies are required. Recently, a cancer stem cell population has been found responsible for the initiation of adult and pediatric brain tumors and may constitute the cellular basis for the resistance of these tumors to chemotherapy and radiotherapy and a more reliable model to study these malignancies. One of the approaches used to design novel, rational, and effective treatments directed against the molecular defects of these tumors involves the use of oncolytic adenoviruses. Our group previously reported the anti-glioma effect of the tumor-selective adenovirus, Delta-24-RGD engineered to selectively replicate in cells that harbor an abnormal RB pathway, a hallmark of cancer. We hypothesize that a targeted oncolytic adenovirus design to target not only the bulk of the tumor but also the BTSCs population, which account for resistance and recurrence, may constitute a significant improvement of the prognosis and quality of life of patient with pediatric brain tumors. Since the percentage of BTSCs would vary along the different pediatric brain tumors this strategy will be likely to be used in combinations, to maximize clinical impact and to minimize opportunities for resistant cancer cells to emerge. Consequently, we shall evaluate the cytotoxic effect of Delta-24-RGD in combination with temozolomide. Importantly, Delta-24-RGD in combination with chemotherapy would avoid the use of radiotherapy which, in turn, will prevent the subsequent loss of cognitive function without compromising disease control and thus, improving the overall quality of life for these children.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores